Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07378215
PHASE4

The Effect of Corticosteroids on Quality of Life Following Total Hip Arthroplasty: HIPSTER Study

Sponsor: Ziekenhuis Oost-Limburg

View on ClinicalTrials.gov

Summary

Total hip arthroplasty (THA) is a highly effective and commonly performed procedure for end-stage osteoarthritis. Perioperative inflammation contributes to postoperative pain, fatigue, and delayed recovery. Dexamethasone, a potent glucocorticoid with strong anti-inflammatory properties, is widely used in orthopedic surgery and incorporated into Enhanced Recovery After Surgery (ERAS) protocols for THA to reduce pain, PONV, and fatigue. While intermediate doses of dexamethasone (25 mg) are considered safe and beneficial in the short term, their long-term effects on health-related quality of life and persistent pain remain unclear. Therefore, the main objective of the HIPSTER trial is to evaluate the effect of different doses of a single intraoperative intravenous dose of dexamethasone (5 mg versus 25 mg) on health-related quality of life up to three months after surgery.

Key Details

Gender

All

Age Range

60 Years - Any

Study Type

INTERVENTIONAL

Enrollment

224

Start Date

2026-01-30

Completion Date

2027-02

Last Updated

2026-04-08

Healthy Volunteers

No

Interventions

DRUG

Dexamethasone (IV)

Dexamethasone 5 mg IV

DRUG

Dexamethasone (IV)

Dexamethasone 25 mg IV

Locations (2)

Ziekenhuis Oost-Limburg

Genk, Limburg, Belgium

Ziekenhuis Oost-Limburg

Genk, Belgium